QA: CytoDyn Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001175680_2023_CytoDyn_Inc.pdf

Logs

Graph

Absolute values for 0001175680, CytoDyn Inc.

  xvar xval
0 AssetsCurrent 10,515,000
1 IntangibleAssetsNetIncludingGoodwill 132,000
2 PropertyPlantAndEquipmentNet 73,000
3 remainder_Assets 18,465,000
4 LiabilitiesCurrent 123,161,000
5 LiabilitiesNoncurrent 422,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 53,000
8 SellingGeneralAndAdministrativeExpense 44,303,000
9 ResearchAndDevelopmentExpense 27,043,000
10 remainder_Expenses 139,687,000
11 remainder_Revenues 266,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 29,185,000
1 Liabilities 123,583,000
2 Expenses 211,086,000
3 Revenues 266,000
4 StockholdersEquity -94,398,000
5 NetIncome -210,820,000
6 ComprehensiveNetIncome -210,820,000
7 BaseVar 182,060,000
8 EconomicCapitalRatio -4.89

Edgar->Model Mapping

Feature Distribution

Change over Time